Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $33.65 in the prior trading day, Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) closed at $30.52, down -9.30%. In other words, the price has decreased by -$9.30 from its previous closing price. On the day, 1.07 million shares were traded.
Ratios:
Our goal is to gain a better understanding of CRNX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.04 and its Current Ratio is at 23.04. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on March 25, 2025, initiated with a Buy rating and assigned the stock a target price of $60.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 19 ’25 when Pizzuti Dana sold 2,515 shares for $34.20 per share. The transaction valued at 86,021 led to the insider holds 72,233 shares of the business.
Knight Jeff E. sold 7,162 shares of CRNX for $244,964 on Mar 19 ’25. The Chief Operating Officer now owns 87,491 shares after completing the transaction at $34.20 per share. On Mar 19 ’25, another insider, Betz Stephen F., who serves as the Chief Scientific Officer of the company, sold 5,770 shares for $34.20 each. As a result, the insider received 197,353 and left with 108,588 shares of the company.
Stock Price History:
Over the past 52 weeks, CRNX has reached a high of $62.53, while it has fallen to a 52-week low of $24.10. The 50-Day Moving Average of the stock is -5.88%, while the 200-Day Moving Average is calculated to be -33.94%.
Shares Statistics:
A total of 92.93M shares are outstanding, with a floating share count of 87.08M. Insiders hold about 6.99% of the company’s shares, while institutions hold 103.91% stake in the company.
